Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA – Ready, Set, Launch: Importance of Evidence at Product Launch

Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA, Vice President, Clinical Data Science & Evidence, NNI, Novo Nordisk – Our 150th Real-World Wednesdays (RWW): we discussed the importance of meaningful RWE at product launch ("Evidence at Launch") and how trial tokenization as well as other methods support these efforts. In addition, a great perspective on the real-world evidence and epidemiology career path.

Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club

Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.